AccessClosure, Inc. Launches The Next-Generation Mynx Ace™ Vascular Closure Device At Annual American College of Cardiology Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AccessClosure Inc., the market leader in extravascular care technology, has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system1 to seal femoral artery access sites. The device joins the pioneering line of Mynx extravascular products that help care teams reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC